Teixobactin — Indexed Studies

The association of psychological distress with microbiota alterations in patients suffering from quiescent inflammatory bowel disease.

Zito L, Conti C, Lanzara R et al.

Crohn's Disease Mimicking Behçet's Disease and Complicated by Colonic Perforation: A Case Report.

Nazir FJ, Zafar Ahmed SSN, Barak Z et al.

Persistence of advanced therapies in patients with ulcerative colitis: real-world data from the nationwide CREdIT registry.

Hradsky O, Duricova D, Lukas M et al.

Evaluation of the effectiveness and safety of anti-CGRP monoclonal antibodies in patients with migraine and autoimmune diseases: IMMUNO-CGRP study.

García-Castillo MC, Sierra-Mencía Á, Caronna E et al.

Timing of ileocolic resection for Crohn's disease: A survey of the patient perspective in the 'biological' era.

Husnoo N, Nongrum R, Hall T et al.

Patient-derived intestinal organoids as a model for site-specific mucosal bacterial interactions in paediatric inflammatory bowel disease.

Chan E, Chan WH, Kerr G et al.

Efficacy and Safety of Titrated High-Dose Cholecalciferol Supplementation in Children and Young Adult Patients with Inflammatory Bowel Disease.

Gordon RJ, Vishwanath V, Lavoie A et al.

Investigating Handgrip Strength as a Practical Biomarker for Therapeutic Endpoints and Nutritional Status in Patients with Inflammatory Bowel Disease.

Vadarlis A, Germanidis G, Maris T et al.

Sleep Architecture Screening in Hospitalized Patients with Inflammatory Bowel Diseases: A Prospective Propensity Score-Matched Analysis.

Zhou X, Wang X

Comparison of microbiota profiles of fecal samples, rectal swabs and mucosal biopsies in patients with inflammatory bowel disease.

van Rossen TM, van den Hoek K, Groot T et al.

The Multiple Dimensions of Self-Management in Active Inflammatory Bowel Disease: A Qualitative Analysis of Patients' Daily Lived Experiences.

Cohen-Mekelburg S, Hodish G, Ebner D et al.

Understanding Patient Preferences on Inflammatory Bowel Disease Treatment Modalities and Outcomes: A Global Targeted Literature Review.

Whittle I, Brown Hajdukova E, Coles H et al.

[A case report of Crohn's disease in a child treated with upadacitinib].

Pan GX, Yang QP, Yang XM et al.

Beyond pharmacotherapy in IBD: feasibility and patient-reported benefits of a six-week multimodal rehabilitation pilot.

Dermine S, Bazin T, Alioui L et al.

Symptom Response Dynamics for Personalised Therapy with Subcutaneous Infliximab in Crohn's Disease: Insights from the Randomised, Placebo-Controlled, Phase 3 LIBERTY-CD Trial.

Schreiber S, Sands BE, Danese S et al.

Actively expressed microbiota in mucosal biopsies of treatment-naïve ulcerative colitis patients.

Karlsholm LS, Ahmad R, Taman H et al.

Fulminant Toxic Megacolon Without Identifiable Underlying Cause Requiring Emergent Total Colectomy: A Case Report.

Flores García EA, Lopez Villicaña HA, Lopez Lopez A et al.

Emergence of Takayasu Arteritis and Chronic Recurrent Multifocal Osteomyelitis during Maintenance Therapy in Remission 13 Years after the Diagnosis of Very Early-Onset Ulcerative Colitis: A Case Report.

Yamane Y, Hashimoto K, Yuda A et al.

Clinical consequences of delayed recognition of gastrointestinal basidiobolomycosis: a case series.

Almasaud A, Alghamdi S, Alzahrani A et al.

Impact of mirikizumab on patient-reported outcomes and quality of life in patients with Crohn's disease: results from the phase 2 SERENITY study.

Jairath V, Hunter Gibble T, Peyrin-Biroulet L et al.

Statin use is associated with lower rates of stricture development in patients with Crohn's disease: a propensity score-matched study of two nationwide population databases.

Dimopoulos-Verma A, Kulkarni C, Pike CW et al.

Intestinal Stem Cells from Patients with Inflammatory Bowel Disease Retain an Epigenetic Memory of Inflammation.

Hamdan FH, Farhadipour M, Perez I et al.

Therapeutic drug monitoring in inflammatory bowel disease patients switching from intravenous to subcutaneous infliximab: insights from a prospective real-world study.

Bergsmark C, Kristensen VA, Sjåmo MB et al.

Usefulness of Nutritional Intervention Through New Digital Technologies in Patients with Inflammatory Bowel Disease.

Suárez Ferrer C, Martorell Mariné I, Rueda García JL et al.

An Unusual Case of Upper Digestive Bleeding-Metastatic Amelanotic Melanoma: Case Report and Literature Review.

Dranga M, Cijevschi Prelipcean C, Nedelciuc O et al.

Clinical Case Report on the Use of Rezafungin in Pneumocystis jirovecii Pneumonia in a Critically Ill Patient.

Fernández-Fernández R, García-Martínez R, Fernández WS et al.

Outcomes of Percutaneous Coronary Intervention in Patients with Inflammatory Bowel Disease.

Bhagat U, Banga A, Agrawal A et al.

Sexual Functioning of Patients with Inflammatory Bowel Disease.

Kotkowicz-Szczur M, Kisielewska L, Kisielewski R et al.

The IBD-FITT Study-Moderate-Intensity Exercise for Patients with Active Inflammatory Bowel Disease: An Open-Label Randomized Controlled Trial.

Lund K, Knudsen T, Kjeldsen J et al.

Factors associated with urgent consultation recommendations for patients with inflammatory bowel disease calling a telephone service about worsening symptoms: a secondary analysis.

Kawakami A, Tanaka M, Sakagami K et al.

Evaluation of serum and dietary profiles of vitamin B12 and folate and their association with systemic complications in patients with Crohn's disease.

de Castro MM, Dos Santos VN, Gomes MS et al.

The SILVER Platter for Patients with Inflammatory Bowel Disease (IBD): An IBD Pharmacy Technician-Led Subcutaneous Biologic Home Delivery Service Is Associated with Sustained Improvement in Adherence and Active Health Management.

Leake A, Bishara M, Lo SW et al.

The Impact of Informal Caregiving on Patient-Reported Outcomes, Psychological Well-Being and Quality of Life in Inflammatory Bowel Disease: A Systematic Review.

Benedetti F, Imperatori G, Amatucci V et al.

Serum Chitinase 3-like-1 (CHI3L1) Has Good Correlation with Fecal Calprotectin Levels in Pregnant IBD Patients.

Schweistein H, Gingold-Belfer R, Rave A et al.

[Guideline for the Treatment of Ulcerative Colitis and Crohn's Disease in Adult Patients].

Núñez F P, Alfaro I, Pavez C et al.

A Review of the Use of Mobile Health Interventions in Patients with Inflammatory Bowel Disease.

Zhang Q, Zhou J, Lei W et al.

Successful nutritional treatment of superior mesenteric artery syndrome in a non-malnourished patient: a case report.

Muller A, Bechet D, de Courtivron B et al.

Correction to: Safety and outcomes of advanced IBD therapies in patients with HIV: a propensity-matched cohort analysis.

Managing Acute Severe Ulcerative Colitis in the Older Patient: A Growing Concern.

Fries W, Costantino G, Viola A

Viral encephalitis related to adalimumab in a 16-year-old Crohn's disease patient: case report and literature review.

Liang Z, Yang Q, Pan G et al.

Corrigendum to "SDH, a novel diarylheptane compound, is a potential treatment for inflammatory bowel disease by restoring epithelial barrier function" [Biomed. Pharmacother. 151 (2022) 113080].

Yang F, Zhu X, Li L et al.

Food-related quality of life in inflammatory bowel disease: validity and reliability of the Brazilian version of the FR-QoL-29-Portuguese-Brazil.

Tuma ISM, Cambi MPC, de Oliveira Dominski SF et al.

Crosstalk between inflammation and autophagy in CeD organoids.

Bellomo C, Furone F, Auricchio R et al.

Long-Term Risk of Inflammatory Bowel Disease With Sarcopenia Status: A Large-Scale Prospective Cohort Study.

Zhang Q, Gui P, Liu S et al.

Platelet-rich fibrin matrix as treatment for complex anal fistulae: A 3-year experience at a tertiary centre.

Lusilla Lopez A, Fält UA, Buchwald P et al.

Gallic acid alleviates colitis by restoring intestinal barrier function and enriching butyrate-producing bacteria.

Zhang Q, Chu C, Wang N et al.

A simple MR enterography assessment of Crohn disease activity based on the most affected bowel segment: A retrospective cohort study.

Seo N, Lim JS, Kim SS et al.

Molecular Ultrasound Imaging With Clinically Translatable cRGD-Coated Microbubbles to Assess αvβ3-Integrin Expression in Inflammatory Bowel Disease: Erratum.

Discovery of Non-prostanoid EP4 Agonists for the Treatment of Inflammatory Bowel Disease.

Perez HL, Dewnani S, Spronk SA et al.

Probiotic novel strain Lactobacillus reuteri MRD01 alleviates dextran sulfate sodium-induced colitis in male mice by promoting intestinal barrier integrity.

Li Y, Ding G, Bao G et al.